申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2014141171A1
公开(公告)日:2014-09-18
The invention relates to compounds of the Formula (I), Formula (I) wherein R1 and R2 are as described in the description, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.
该发明涉及公式(I)的化合物,其中R1和R2如描述中所述,它们的制备以及它们作为药用活性化合物的用途。这些化合物特别作为免疫调节剂。